Search clinical trials for: Immunoglobulin Idiotypes

Total 1478 results

National Cancer Institute (NCI)

Completed

Active Immunization of Sibling Bone Marrow Transplant Donors Against Purified Myeloma Protein of the Recipient Undergoing Allogeneic Bone Marrow Transplantation

Multiple Myeloma | Graft vs Host Disease

United States
Genitope Corporation

Terminated

Personalized Active Immunotherapy (Vaccine Therapy) and Sargramostim Given After Standard of Care Treatment With Rituximab and Chemotherapy for Initial Treatment With Lymphoma

Non-Hodgkin's Lymphoma

United States
Favrille
National Cancer Institute (NCI)

Terminated

Vaccine Therapy and GM-CSF in Treating Patients With Progressive Non-Hodgkin's Lymphoma

Lymphoma

United States
Genitope Corporation

Completed

Vaccine Therapy and Sargramostim After Rituximab in Treating Patients With Refractory or Progressive Non-Hodgkin's Lymphoma

Lymphoma

United States, Canada
University Hospital Carl Gustav Carus

Completed

Dendritic Cells(DC)-Based Id Vaccination in Stage-I Myeloma

Multiple Myeloma | Plasmocytoma

Germany
Favrille

Unknown

Rituximab, Vaccine Therapy, and GM-CSF in Treating Patients With Non-Hodgkin's Lymphoma

Lymphoma

United States
Favrille

Terminated

Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's Lymphoma

Lymphoma

United States
Stanford University
National Cancer Institute (NCI)

Completed

Vaccine Therapy for Multiple Myeloma Utilizing Idiotype-Pulsed Allogeneic Dendritic Cells

Multiple Myeloma

United States
Radiation Therapy Oncology Group
National Cancer Institute (NCI)

Completed

Vaccine Therapy Plus Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer That Has Been Completely Removed in Surgery

Lung Cancer

United States, Canada
Clinica Universidad de Navarra, Universidad de...
University of Navarrra Hospital (Clinica Universitaria); Center for Applied...

Unknown

Idiotypic Vaccination for Follicular Lymphoma Patients (FLIDVAX2006)

Follicular Lymphoma | First Relapse/Progression

Spain
Southwest Oncology Group
National Cancer Institute (NCI)

Terminated

S0122: Combination Chemotherapy, Radiation Therapy, and Vaccine Therapy in Limited-Stage Small Cell Lung Cancer

Lung Cancer

United States, Canada
Fred Hutchinson Cancer Research Center/University...
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Multiple Myeloma Who Have Undergone Stem Cell Transplantation

Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple Myeloma | Refractory Multiple Myeloma

United States
University of Texas Southwestern Medical Center

Withdrawn

Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma

Lymphoma | Small Intestine Cancer | Brain and Central Nervous System Tumors | Lymphoproliferative Disorder

United States
Genitope Corporation

Unknown

Combination Chemotherapy Followed By Vaccine Therapy Plus Sargramostim in Treating Patients With Stage III or Stage IV Non-Hodgkin's Lymphoma

Lymphoma

United States, Canada
Assiut University

Unknown

Evaluation Of Pleural Effusion At Assiut University Hospital

Pleural Effusion
Universidad Politecnica de Madrid

Recruiting

Immunoglobulin G4 and Immunoglobulin E Antibodies in a Population With Adverse Reactions to Foodstuffs-related Symptoms

Immunoglobulin G4-Related Disease | Symptoms and Signs | Immunoglobulin E-Mediated Food Allergy | Adverse Reaction to Food

Spain
Hospital Italiano de Buenos Aires

Completed

Immunity Against COVID-19 Vaccine in Healthcare Workers in Argentine

Healthcare Workers | Vaccine | Coronavirus 2019

Argentina
Technische Universität Dresden
GWT-TUD GmbH

Completed

Assessment of Immunoglobulins (IgG) in a Long-term Non-interventional Study (SIGNS)

Primary Immunodeficiency (PID) | Secondary Immunodeficiency (SID) | Neurological Autoimmune Disease

Germany
Assiut University

Unknown

Serum Immunoglobulin (G) as a Marker of Diabetic Nephropathy

Diabetic Nephropathies
University Health Network, Toronto

Recruiting

Subcutaneous Immunoglobulin for Myasthenia Gravis (MG_SCIG)

Myasthenia Gravis

Canada
Thomas Jefferson University

Terminated

Subcutaneous Immunoglobulin (Hizentra) in Patients With Dermatomyositis: A Proof of Concept Study

Dermatomyositis

United States
Massimo Girardis

Recruiting

Efficacy and Safety of Therapy With IgM-enriched Immunoglobulin With a Personalized Dose vs Standard Dose in Patients With Septic Shock. (IgM-FAT)

Sepsis | Shock, Septic | Hypoglobulinemia

Italy
University of Alberta
CSL Behring

Completed

A Pilot Trial To Assess The Feasibility And Efficacy Of SCIG In Patients With MG Exacerbation (SCIG-MG) (SCIG-MG)

Myasthenia Gravis

Canada
National Eye Institute (NEI)

Completed

Intravenous Immunoglobulin Therapy in Optic Neuritis

Optic Neuritis

United States
University of Aarhus
Odense University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark; Aalborg University Hospital

Recruiting

Subcutaneous Immunoglobulin in De-novo CIDP (SIDEC) (SIDEC)

CIDP - Chronic Inflammatory Demyelinating Polyneuropathy

Denmark
Medical University of South Carolina
Entera Health, Inc

Completed

Efficacy of Serum Bovine Immunoglobulin in Improving Nutritional Status in Advanced COPD (SBI for COPD)

Advanced COPD (GOLD Stage 3 or 4) With Cachexia

United States
Assistance Publique - Hôpitaux de Paris

Completed

Immunotherapy and Paraneoplastic Neurological Syndromes (IaSON)

Paraneoplastic Neurological Syndromes

France
CSL Behring

Active, not recruiting

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 in Adults With Dermatomyositis (DM) (RECLAIIM)

Dermatomyositis

United States, Argentina, Belgium, France, Germany, Hungary, Italy, Japan, Mexico, Poland, Russian Federation, Spain, Switzerland, Ukraine
Assistance Publique - Hôpitaux de Paris
CSL Behring; Association ASLUMARE

Completed

Effect of Privigen Against Graft Loss (InAuGuRAL)

Kidney Transplantation

France
Wei Wang

Unknown

Intravenous Immunoglobulin for Acute Intracranial Hemorrhage

Intracranial Hemorrhage, Hypertensive

China
CSL Limited

Completed

Safety Study of Subcutaneous Ig NextGen 16% in Patients With Primary Immunodeficiency

Primary Immune Deficiency

Australia, New Zealand
BriovaRx Infusion Services

Terminated

Gamma Globulin Observations and Outcomes Database for Patients With Primary Immunodeficiency Disease (GOOD-SHEPARD-PI)

Primary Immune Deficiency Disorder

United States
University of Aarhus

Completed

Subcutaneous Immunoglobulin Treatment for Multifocal Motor Neuropathy

Multifocal Motor Neuropathy

Denmark
Fundacion GESICA
Merck Sharp & Dohme LLC

Recruiting

A Dengue Sero-prevalence Study in the Metropolitan Area of Buenos Aires

Flavivirus Infections | Dengue

Argentina
Assiut University

Unknown

Clinical Study for Efficacy of Anti-Corona VS2 Immunoglobulins Prepared From COVID19 Convalescent Plasma Prepared by VIPS Mini-Pool IVIG Medical Devices in Prevention of SARS-CoV-2 Infection in High Risk Groups as Well as Treatment of Early Cases of COVID19 Patients

COVID19
Green Cross Corporation

Completed

Safety and Efficacy of IGIV 10% in Patients With Autoimmune Encephalitis:

Autoimmune Encephalitis

Korea, Republic of
National Institute of Allergy and Infectious Diseases...

Completed

Prevention of RSV Infections in Bone Marrow Transplant Recipients

Respiratory Syncytial Virus Infection

United States
Biotest
Syneos Health

Completed

This Clinical Study is to Test Efficacy and Safety of BT595 in Chronic Primary Immune Thrombocytopenia (ITP)

Immune Thrombocytopenia

Bulgaria, Czechia, Germany, Hungary, Serbia, Spain
Hannover Medical School

Recruiting

PredIcting sterOid depeNdEnt livEr injuRy With Polyreactive Immunoglobulin G (PIONEER)

Autoimmune Liver Disease | Autoimmune Hepatitis

Germany
St. Louis University
American College of Gastroenterology; Entera Health, Inc

Completed

Evaluation of Serum-Derived Bovine Immunoglobulin Protein Isolate in Subjects With Decompensated Cirrhosis With Ascites

Ascites | Spontaneous Bacterial Peritonitis | Cirrhosis of the Liver

United States
University Health Network, Toronto
CSL Behring

Completed

Subcutaneous Ig in Allogeneic Stem Cell Transplant Recipients (ScIGalloHCT)

Hypogammaglobulinemia

Canada
Oxford University Clinical Research Unit, Vietnam
Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam

Completed

Intrathecal Tetanus Immunoglobulin to Treat Tetanus (ITITTT)

Tetanus

Vietnam
Ajou University School of Medicine

Unknown

IVIG Treatment for Asthmatic Patients With IgG Subclass Deficiency (IVIG)

Asthma
Health Science Center of Xi'an Jiaotong University

Completed

Prevention for Mother-to-infant Transmission of HBV

HBV
The University of Hong Kong
Queen Elizabeth Hospital, Hong Kong; Queen Mary Hospital, Hong Kong; Pamela Youde... and other collaborators

Completed

H-IVIG Treatment for Severe H1N1 2009

Novel 2009 Influenza A (H1N1) Infection

Hong Kong
Ajou University School of Medicine

Completed

Study of Autologous Total Immunoglobulin G Therapy for Atopic Dermatitis

Dermatitis, Atopic

Korea, Republic of
University Medicine Greifswald
Fresenius Medical Care North America

Withdrawn

Immunoadsorption and Immunoglobulin Substitution for Heart Failure After Myocardial Infarction

Heart Failure | Coronary Heart Disease

Germany
Green Cross Corporation
Symyoo

Terminated

GCIV as an Adjuvant Therapy for Community-Acquired Severe Sepsis or Septic Shock

Septic Shock | Severe Sepsis

Korea, Republic of
Ottawa Hospital Research Institute

Not yet recruiting

Switched Memory B-cells as a Marker for Humoral Immune System Recovery in Patients With Secondary Antibody Deficiency Due to Hematological Malignancies (SAD)

Secondary Antibody Deficiency
Therapure Biopharma Inc

Unknown

Study of PlasmaCap IG in Adults and Children With PIDD

Primary Immune Deficiency Diseases (PIDD)

United States, Canada

Search clinical trials for: Immunoglobulin Idiotypes

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Armenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations